QualityStocksNewsBreaks – Adaptogenics Health Corp. (CSE: ADPT) Advances Peptide Innovation and GLP-1 Companion Strategy
Disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising. Adaptogenics (CSE: ADPT) is positioning to capitalize on potential changes in U.S. peptide regulations that could expand access through specialty pharmacies and telehealth platforms. As the FDA considers allowing additional peptides for pharmacy compounding, the company plans to differentiate itself by developing proprietary peptide formulations and delivery technologies designed to improve stability, absorption, administration and performance. Adaptogenics has also acquired nutritional research assets from Berkwood Research to support a GLP-1 companion initiative focused on preserving muscle mass, strength and metabolic health during medically induced weight loss. Recent leadership…